Insider trading

Period: 120 months Stock: DYN Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

154 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

154 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

154 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

154 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
154 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
154 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

154 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
8 Sep 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$24.36K 1,290 at 18.88
0.8%
Planned (10b5-1)
8 Sep 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$3.49K 185 at 18.88
0.1%
Planned (10b5-1)
4 Sep 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$91.19K 3,745 at 24.35
2.2%
Planned (10b5-1)
4 Sep 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$21.92K 900 at 24.35
0.6%
Planned (10b5-1)
13 Aug 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$40.89K 1,556 at 26.28
0.9%
Planned (10b5-1)
13 Aug 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$5.94K 226 at 26.28
0.1%
Planned (10b5-1)
16 Jun 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$16.26K 887 at 18.33
0.5%
Planned (10b5-1)
16 Jun 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$2.66K 145 at 18.33
0.1%
Planned (10b5-1)
13 May 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$28.72K 1,564 at 18.36
0.9%
Planned (10b5-1)
13 May 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$4.19K 228 at 18.36
0.1%
Planned (10b5-1)
5 Mar 2026
Kerr Douglas Chief Medical Officer
Sold on a plan
$13.47K 904 at 14.90
0.5%
Planned (10b5-1)
5 Mar 2026
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$2.21K 148 at 14.90
0.1%
Planned (10b5-1)
5 Dec 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$18.23K 880 at 20.72
1.0%
Planned (10b5-1)
5 Dec 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$2.98K 144 at 20.72
0.2%
Planned (10b5-1)
5 Sep 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$11.71K 873 at 13.41
1.0%
Planned (10b5-1)
5 Sep 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.93K 144 at 13.41
0.2%
Planned (10b5-1)
4 Sep 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$47.14K 3,552 at 13.27
3.8%
Planned (10b5-1)
4 Sep 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$11.86K 894 at 13.27
0.9%
Planned (10b5-1)
5 Jun 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$17.92K 1,342 at 13.35
1.4%
Planned (10b5-1)
5 Jun 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.95K 146 at 13.35
0.2%
Planned (10b5-1)
13 Mar 2025
Friedl-Naderer Johanna Chief Commercial Officer
Sold on a plan
$1.73K 143 at 12.12
0.1%
Planned (10b5-1)
11 Mar 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$24.50K 2,153 at 11.38
1.1%
Planned (10b5-1)
11 Mar 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$15.28K 1,343 at 11.38
1.1%
Planned (10b5-1)
5 Mar 2025
Kerr Douglas Chief Medical Officer
Sold on a plan
$15.89K 1,343 at 11.83
1.4%
Planned (10b5-1)
5 Mar 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$12.94K 1,094 at 11.83
0.5%
Planned (10b5-1)
5 Mar 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$10.85K 917 at 11.83
0.7%
Planned (10b5-1)
18 Feb 2025
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$36.24K 2,598 at 13.95
1.3%
Planned (10b5-1)
18 Feb 2025
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$34.71K 2,488 at 13.95
2.0%
Planned (10b5-1)
11 Dec 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$65.63K 2,334 at 28.12
1.1%
Planned (10b5-1)
11 Dec 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$40.91K 1,455 at 28.12
1.1%
Planned (10b5-1)
18 Nov 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$80.54K 2,856 at 28.20
2.0%
Planned (10b5-1)
18 Nov 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$77.13K 2,735 at 28.20
2.8%
Planned (10b5-1)
18 Sep 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan 2×
$308.86K 8,976 at 34.41
6.4%
Planned (10b5-1)
18 Sep 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$80.81K 2,339 at 34.55
1.6%
Planned (10b5-1)
18 Sep 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$48.02K 1,390 at 34.55
1.4%
Planned (10b5-1)
11 Sep 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan 2×
$168.06K 5,270 at 31.89
3.6%
Planned (10b5-1)
11 Sep 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan
$68.91K 2,161 at 31.89
1.5%
Planned (10b5-1)
11 Sep 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan
$46.81K 1,468 at 31.89
1.4%
Planned (10b5-1)
6 Sep 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold at will 2×
$4.05M 126,074 at 32.15
55.4%
Sold half or more
19 Aug 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan 2×
$131.30K 2,910 at 45.12
2.0%
Planned (10b5-1)
19 Aug 2024
Scalzo Richard William SVP, Head of Finance & Admin.
Sold on a plan 2×
$124.17K 2,752 at 45.12
2.4%
Planned (10b5-1)
19 Aug 2024
McNeill Jonathan Chief Business Officer
Sold on a plan 2×
$122.05K 2,705 at 45.12
2.0%
Planned (10b5-1)
19 Aug 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold on a plan 2×
$118.94K 2,636 at 45.12
1.8%
Planned (10b5-1)
19 Aug 2024
Farwell Wildon Chief Medical Officer
Sold on a plan 2×
$104.73K 2,321 at 45.12
1.6%
Planned (10b5-1)
24 Jun 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan
$359.06K 10,163 at 35.33
6.4%
Planned (10b5-1)
21 Jun 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan
$1.04M 29,787 at 35.01
16.7%
Planned (10b5-1)
12 Jun 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan 2×
$1.33M 40,000 at 33.36
21.2%
Planned (10b5-1)
11 Jun 2024
HIGH SUSANNA GATTI Chief Operating Officer
Sold on a plan 2×
$164.58K 5,270 at 31.23
3.4%
Planned (10b5-1)
11 Jun 2024
Farwell Wildon Chief Medical Officer
Sold on a plan 2×
$82.43K 2,636 at 31.27
1.8%
Planned (10b5-1)
11 Jun 2024
Beskrovnaya Oxana Chief Scientific Officer
Sold at will
$66.94K 2,136 at 31.34
1.4%
Not planned
Showing 1–50 of 154. Page 1 of 4 Older →